AAAAAA

   
Results: 1-14 |
Results: 14
INTENSIFIED AND HIGH-DOSE CHEMOTHERAPY WITH GRANULOCYTE-COLONY-STIMULATING FACTOR AND AUTOLOGOUS STEM-CELL TRANSPLANTATION SUPPORT AS FIRST-LINE THERAPY IN HIGH-RISK DIFFUSE LARGE-CELL LYMPHOMA
Authors: VITOLO U CORTELLAZZO S LIBERATI AM FREILONE R FALDA M BERTINI M BOTTO B CINIERI S LEVIS A LOCATELLI F LOVISONE E MARMONT F PIZZUTI M ROSSI A VIERO P BARBUI T GRIGNANI F RESEGOTTI L
Citation: U. Vitolo et al., INTENSIFIED AND HIGH-DOSE CHEMOTHERAPY WITH GRANULOCYTE-COLONY-STIMULATING FACTOR AND AUTOLOGOUS STEM-CELL TRANSPLANTATION SUPPORT AS FIRST-LINE THERAPY IN HIGH-RISK DIFFUSE LARGE-CELL LYMPHOMA, Journal of clinical oncology, 15(2), 1997, pp. 491-498
IDARUBICIN IN PATIENTS WITH DIFFUSE LARGE-CELL LYMPHOMAS - A RANDOMIZED TRIAL COMPARING VACOP-B (A=DOXORUBICIN) VS VICOP-B (I=IDARUBICIN)
Authors: BERTINI M FREILONE R BOTTO B CALVI R GALLAMINI A GATTI AM LIBERATI AM MENEGHINI V ORLANDI E ORSUCCI L PIZZUTI M SCALABRINI DR SALVI F TODESCHINI G VITOLO U RESEGOTTI L
Citation: M. Bertini et al., IDARUBICIN IN PATIENTS WITH DIFFUSE LARGE-CELL LYMPHOMAS - A RANDOMIZED TRIAL COMPARING VACOP-B (A=DOXORUBICIN) VS VICOP-B (I=IDARUBICIN), Haematologica, 82(3), 1997, pp. 309-313
EFFECT OF HYPEROXIA ON RAT CAROTID-BODY NITRIC-OXIDE SYNTHASE
Authors: DIGIULIO C DELUTIIS MA DINATALE F GRILLI A CACCHIO M LOFFREDO B MANCINI A PIZZUTI M SABATINO G FELACO M
Citation: C. Digiulio et al., EFFECT OF HYPEROXIA ON RAT CAROTID-BODY NITRIC-OXIDE SYNTHASE, Pflugers Archiv, 434(3), 1997, pp. 80-80
CHRONIC MYELOID-LEUKEMIA, BCR ABL TRANSCRIPT, RESPONSE TO ALPHA-INTERFERON AND SURVIVAL/
Authors: BACCARANI M TURA S RUSSO D BACCARANI M ZACCARIA A SAGLIO G GUERRASIO A MARTINELLI G ZUFFA E TESTONI N FARABEGOLI P ZAMAGNI MD FANIN R DAMIANI D DEMILIO A BATTISTA R SPECCHIA G LISO V DITUCCI A BROCCIA G MONTEFUSCO E MANDELLI F RAMBALDI A BARBUI T BODENIZZA CA CAROTENUTO M ROTONDO SG AMBROSETTI A PERONA G LUCIANO L ROTOLI B RONCO F NOBILE F TABILIO A LIBERATI A MARTELLI M GRIGNANI F PARDINI S LONGINOTTI M GENTILINI I COSER P LEONI F CIOLLI S MORRA E BERNASCONI C FERRERO D PILERI A LEONI P DANIELI G ABBADESSA A BRUZZESE L TRINGALI S CARONIA F GALIENI P DISPENSA E NOVARINO A CAPUCCI A IZZI T NOSARI A PIZZUTI M RICCIUTI F VASINO AC RESEGOTTI L CAPALDI A GIOVANNELLI E
Citation: M. Baccarani et al., CHRONIC MYELOID-LEUKEMIA, BCR ABL TRANSCRIPT, RESPONSE TO ALPHA-INTERFERON AND SURVIVAL/, Leukemia, 9(10), 1995, pp. 1648-1652
INTENSIFIED CHEMOTHERAPY FOLLOWED BY MYELOABLATIVE THERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) AS FIRST LINE THERAPY IN HIGH-RISK DIFFUSE LARGE-CELL LYMPHOMA (DLCL)
Authors: VITOLO U CORTELLAZZO S LIBERATI AM FREILONE R FALDA M BERTINI M BOTTO B CINIERI S LOCATELLI F MARMONT F PIZZUTI M ROSSI A VIERO P GRIGNANI F BARBUI T RESEGOTTI L
Citation: U. Vitolo et al., INTENSIFIED CHEMOTHERAPY FOLLOWED BY MYELOABLATIVE THERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) AS FIRST LINE THERAPY IN HIGH-RISK DIFFUSE LARGE-CELL LYMPHOMA (DLCL), Blood, 86(10), 1995, pp. 1819-1819
A PHASE-II TRIAL ON ALPHA-INTERFERON (ALPHA-IFN) EFFECT IN PATIENTS WITH MONOCLONAL IGM GAMMOPATHY
Authors: ROTOLI B DERENZO A FRIGERI F BUFFARDI S MARCENO R CAVALLARO AM RUGGERI P LISO V MUSTO P ANDRIANI A CALLEA V PIZZUTI M IANNITTO E CIMINO R MOLICA S CITARRELLA P MUSOLINO C GUARINO S LUCARELLI G ESPINOSA A DELVECCHIO L
Citation: B. Rotoli et al., A PHASE-II TRIAL ON ALPHA-INTERFERON (ALPHA-IFN) EFFECT IN PATIENTS WITH MONOCLONAL IGM GAMMOPATHY, Leukemia & lymphoma, 13(5-6), 1994, pp. 463-469
P-VEBEC - A NEW 8-WEEKLY SCHEDULE WITH OR WITHOUT RG-CSF FOR ELDERLY PATIENTS WITH AGGRESSIVE NON-HODGKINS-LYMPHOMA (NHL)
Authors: BERTINI M FREILONE R VITOLO U BOTTO B PIZZUTI M GAVAROTTI P LEVIS A ORLANDI E ORSUCCI L PINI M SCALABRINI DR SALVI F SECONDO V TODESCHINI G VIERO P VOLTA C RESEGOTTI L
Citation: M. Bertini et al., P-VEBEC - A NEW 8-WEEKLY SCHEDULE WITH OR WITHOUT RG-CSF FOR ELDERLY PATIENTS WITH AGGRESSIVE NON-HODGKINS-LYMPHOMA (NHL), Annals of oncology, 5(10), 1994, pp. 895-900
CYCLOPHOSPHAMIDE AND DEXAMETHASONE (CD) VERSUS CD-PLUS-INTERFERON-ALPHA-2B (IFN-CD) FOR RESISTANT OR RELAPSED MULTIPLE-MYELOMA
Authors: MARCENO R BUSCEMI F FIANDACA T MOLICA S ALBERTI A RUGGERI P ARDIZZONE G DERENZO A ROTOLI B IANNITTO E ABBADESSA V MUSTO P CAROTENUTO M DERIU L CALLEA V ANDRIANI A MUSOLINO C PIZZUTI M RENNA S CARONIA F
Citation: R. Marceno et al., CYCLOPHOSPHAMIDE AND DEXAMETHASONE (CD) VERSUS CD-PLUS-INTERFERON-ALPHA-2B (IFN-CD) FOR RESISTANT OR RELAPSED MULTIPLE-MYELOMA, Experimental hematology, 22(8), 1994, pp. 734-734
INTERFERON ALFA-2A AS COMPARED WITH CONVENTIONAL CHEMOTHERAPY FOR THETREATMENT OF CHRONIC MYELOID LEUKEMIA
Authors: TURA S BACCARANI M ZUFFA E RUSSO D ZACCARIA A FIACCHINI M TESTONI N ZAMAGNI MD MARTINELLI G DAMIANI D MICHIELI M FOWST C HOLDENER EE SPECCHIA G LISO V MORRA E BERNASCONI C ALIMENA G MANDELLI F LEONI P DANIELI G NOSARI A DECATALDO F MAJOLINO I CARONIA F LIBERATI AM GRIGNANI F TABILIO A MARTELLI M PAOLINO F RESEGOTTI L DITUCCI A BROCCIA G LEONI F CIOLLI S LUCIANO L ROTOLI B PERRICONE R CAJOZZO A MONTUORO A DELAURENZI A VOLPE E DEMILIO A BATTISTA R CAPUCCI A IZZI T SCAPOLI GL CASTOLDI GL LOMBARDO M TORLONTANO G LANDOLFI R LEONE G DELFINI C SPARAVENTI G PAPINESCHI F SPREMOLLA G RISSO M MARMONT AM DINI D DIPRISCO U MANGONI L RIZZOLI V GIRINO M ASCARI E BODENIZZA CA CAROTENUTO M DIFRANCESCO A QUAGLINO D NARDELLI S CICCONE F MIRAGLIA E DEBIASE R GALLO E PILERI A RAMBALDI A BARBUI T MORANDI S BIANCHINI E DEROSA C CIMINO R RONCA F NOBILE F CANTONETTI M PAPA G GALLAMINI A BUFFA F MUSOLINO C SQUADRITO G CAPALDI A GIOVANNELLI E PINOTTI G VENCO A ZAGONEL V PINTO A GENTILINI I COSER P GUGLIELMO P CACCIOLA E PIZZUTI M RICCIUTI F FANIN R CRISCUOLO D MONTEFUSCO E
Citation: S. Tura et al., INTERFERON ALFA-2A AS COMPARED WITH CONVENTIONAL CHEMOTHERAPY FOR THETREATMENT OF CHRONIC MYELOID LEUKEMIA, The New England journal of medicine, 330(12), 1994, pp. 820-825
PROGNOSTIC FACTORS IN CHRONIC MYELOID-LEUKEMIA - RELATIONSHIP WITH INTERFERON AND BONE-MARROW TRANSPLANTATION
Authors: TURA S RUSSO D FANIN R ZUFFA E PATRIARCA F FIACCHINI M BACCARANI M TESTONI N ZAMAGNI MD ZACCARIA A MONTEFUSCO E ALIMENA G MELONI G MANDELLI F DAMIANI D MICHIELI M SILVESTRI F VIRGOLINI L CRISCUOLO D FOWST C HOLDENER EE SPECCHIA G LISO V MORRA E BERNASCONI C DEMILIO A BATTISTA R DITUCCI A BROCCIA G MAJOLINO I CARONIA F LUCIANO L ROTOLI B LEONI P BODENIZZA CA CAROTENUTO M ROTONDO SG NOSARI A DECATALDO F MONTUORO A DELAURENZI A LIBERATI AM TABILIO A MARTELLI M RAMBALDI A BARBUI T LEONI F CIOLLI S RONCA F NOBILE F PAOLINO F RESEGOTTI L PAPINESCHI F SPREMOLLA G LANDOLFI R LEONE G VOLPE E MANGONI L RIZZOLI V CAPUCCI A IZZI T GENTILINI I COSER P GALLO E PILERI A CANTONETTI M PAPA G DINI D DIPRISCO U MORANDI S BIANCHINI E PINOTTI G VENCO A ZAGONEL V PINTO A CAPALDI A GIOVANNELLI E PIZZUTI M RICCIUTI F AMBROSETTI A PERONA G PERRICONE R CAJOZZO A LOMBARDO M TORLONTANO G DELFINI C LUCARELLI G GIRINO M ASCARI E
Citation: S. Tura et al., PROGNOSTIC FACTORS IN CHRONIC MYELOID-LEUKEMIA - RELATIONSHIP WITH INTERFERON AND BONE-MARROW TRANSPLANTATION, Leukemia & lymphoma, 11, 1993, pp. 67-71
WILL MOLECULAR-BIOLOGY CONTRIBUTE TO REFINE PROGNOSIS AND TO SELECT TREATMENT
Authors: ZACCARIA A MARTINELLI G BUZZI M FARABEGOLI P SAGLIO G GUERRASIO A BERNABEI PA SANTINI V PELLICCI PG MENCARELLI A COCO FL DIVERIO D RAMBALDI A SANTORO A TURA S RUSSO D ZUFFA E FANIN R PATRIARCA F FIACCHINI M BACCARANI M TESTONI N ZAMAGNI MD ZACCARIA A MONTEFUSCO E ALIMENA G MELONI G MANDELLI F DAMIANI D MICHIELI M CRISCUOLO D FOWST C HOLDENER EE SPECCHIA G LISO V MORRA E BERNASCONI C DEMILIO A BATTISTA R DITUCCI A BROCCIA G MAIOLINO I CARONIA F LUCIANO L ROTOLI B LEONI P DANIELI G BODENIZZA CA CAROTENUTO M ROTONDO SG NOSARI A DECATALDO F MONTUORO A DELAURENZI A CAMILLO S LIBERATI AM GRIGNANI F TABILIO A MARTELLI M RAMBALDI A BARBUI T LEONI F CIOLLI S RONCA F NOBILE F PAOLINO F RESEGOTTI L PAPINESCHI F SPREMOLLA G LANDOLFI R LEONE G VOLPE E MANGONI L RIZZOLI V CAPUCCI A IZZI T SCAPOLI GL CASTOLDI GL GENTILINI I COSER P GALLO E PILERI A CANTONETTI M PAPA G DINI D MORANDI S BIANCHINI E PINOTTI G VENCO A ZAGONEL V PINTO A CAPALDI A GIOVANNELLI E PIZZUTI M RICCIUTI F AMBROSETTI A CAJOZZO A LOMBARDO M TORLONTANO G DELFINI C LUCARELLI G GIRINO M ASCARI E RISSO M DAMASIO E MARTINO S PARDINI S LONGINOTTI M MIRAGLIA E DEBIASE R NARDELLI S GALIENI P DISPENSA E ABBADESSA A BRUZZESE L PROSSOMARITI L CIMINO R DEROSA C GABBAS A FRANCESCO S GALLAMINI A DIFRANCESCO A QUAGLINO D MUSOLINO C SQUADRITO G AVANZINI P GOBBI F NUOVA ASM EMILIA R SAGLIO G AGLIETTA M CAMASCHELLA C MAZZA MU GUGLIELMO P CACCIOLA E MONACO M
Citation: A. Zaccaria et al., WILL MOLECULAR-BIOLOGY CONTRIBUTE TO REFINE PROGNOSIS AND TO SELECT TREATMENT, Leukemia & lymphoma, 11, 1993, pp. 81-89
TREATMENT OF PH-POSITIVE CHRONIC MYELOID-LEUKEMIA WITH ALPHA-INTERFERON (ROFERON-A) - THE ITALIAN COOPERATIVE STUDY-GROUP EXPERIENCE
Authors: TURA S RUSSO D ZUFFA E FANIN R PATRIARCA F FIACCHINI M BACCARANI M TESTONI N ZAMAGNI MD ZACCARIA A MONTEFUSCO E ALIMENA G MELONI G MANDELLI F DAMIANI D MICHIELI M CRISCUOLO D FOWST C HOLDENER EE SPECCHIA G LISO V MORRA E BERNASCONI C DEMILIO A BATTISTA R DITUCCI A BROCCIA G MAIOLINO I CARONIA F LUCIANO L ROTOLI B LEONI P DANIELI G BODENIZZA CA CAROTENUTO M ROTONDO SG NOSARI A DECATALDO F MONTUORO A DELAURENZI A CAMILLO S LIBERATI AM GRIGNANI F TABILIO A RAMBALDI A BARBUI T LEONI F CIOLLI S RONCA F NOBILE F PAOLINO F RESEGOTTI L PAPINESCHI F SPREMOLLA G LANDOLFI R LEONE G VOLPE E MANGONI L RIZZOLI V CAPUCCI A IZZI T SCAPOLI GL CASTOLDI GL GENTILINI I COSER P GALLO E PILERI A CANTONETTI M PAPA G DINI D DIPRISCO U MORANDI S BIANCHINI E PINOTTI G VENCO A ZAGONEL V PINTO A CAPALDI A GIOVANNELLI E PIZZUTI M RICCIUTI F AMBROSETTI A PERONA G PERRICONE R CAJOZZO A LOMBARDO M TORLONTANO G DELFINI C LUCARELLI G GIRINO M ASCARI E RISSO M DAMASIO E MARTINO S PARDINI S LONGINOTTI M MIRAGLIA E DEBIASE R NARDELLI S CICCONE F GALIENI P DISPENSA E ABBADESSA A BRUZZESE L PROSSOMARITI L CIMINO R DEROSA C GABBAS A FRANCESCO S GALLAMINI A DIFRANCESCO A QUAGLINO D MUSOLINO C SQUADRITO G AVANZINI P GOBBI F NUOVA ASM EMILIA R SAGLIO G AGLIETTA M CAMASCHELLA C MAZZA MU GUGLIELMO P CACCIOLA E MONACO M
Citation: S. Tura et al., TREATMENT OF PH-POSITIVE CHRONIC MYELOID-LEUKEMIA WITH ALPHA-INTERFERON (ROFERON-A) - THE ITALIAN COOPERATIVE STUDY-GROUP EXPERIENCE, Leukemia & lymphoma, 11, 1993, pp. 153-157
KARYOTYPIC CONVERSION BY INTERFERON AS PREPARATIVE TREATMENT FOR AUTOLOGOUS BMT IN PH POSITIVE CML
Authors: GOBBI M TURA S RUSSO D ZUFFA E PATRIARCA F FIACCHINI M GOBBI M BACCARANI M MONTEFUSCO E MELONI G MANDELLI F ZAMAGNI MD TESTONI N ZACCARIA A FANIN R DAMIANI D MICHIELI M CRISCUOLO D FOWST C HOLDENER EE SPECCHIA G LISO V DEMILIO A BATTISTA R DITUCCI A BROCCIA G BODENIZZA CA CAROTENUTO M ROTONDO G AMBROSETTI A PERONA G MAJOLINO I CARONIA F LUCIANO L ROTOLI B MORRA E BERNASCONI C RAMBALDI A BARBUI T RONCO F NOBILE F LEONI P NOSARI A DECATALDO F MONTUORO A DELAURENZI A CAMILLO S GENTILINI I COSER P DINI D DIPRISCO U PAPINESCHI F SPREMOLLA G LIBERATI A GRIGNANI G TABILIO A MARTELLI M PARDINI S LONGINOTTI M MANGONI L RIZZOLI V GALIENI P DISPENSA E ABBADESSA A BRUZZESE L LEONI F CIOLLI S CANTONETTI M PAPA G LANDOLFI R LEONE G GALLO E PILERI A ZAGONEL V PINTO A VOLPE E DIFRANCESCO A QUAGLINO D AVANZINI P GOBBI F PAOLINO F RESEGOTTI L SAGLIO G CAMASCHELLA C MAZZA U PINOTTI G VENCO G CAPUCCI A IZZI T MORANDI S BIANCHINI E SCAPOLI GL MONACO M PIZZUTI M RICCIUTI F CAPALDI A GIOVANNELLI E
Citation: M. Gobbi et al., KARYOTYPIC CONVERSION BY INTERFERON AS PREPARATIVE TREATMENT FOR AUTOLOGOUS BMT IN PH POSITIVE CML, Leukemia & lymphoma, 11, 1993, pp. 277-280
EVALUATING SURVIVAL AFTER ALLOGENEIC BONE-MARROW TRANSPLANT FOR CHRONIC MYELOID-LEUKEMIA IN CHRONIC PHASE - A COMPARISON OF TRANSPLANT VERSUS NO-TRANSPLANT IN A COHORT OF 258 PATIENTS 1ST SEEN IN ITALY BETWEEN1984 AND 1986
Authors: TURA S FANIN R RUSSO D ZUFFA F FIACCHINI M BACCARANI M TESTONI N ZAMAGNI D ZACCARIA A DAMIANI D MICHIELI M ALIMENA G MONTEFUSCO E MANDELLI F MORRA E BERNASCONI C GUGLIELMI P CACCIOLA E BATTISTA R DINI E SPECCHIA G LISO V MAJOLINO I CARONIA F LEONI P DANIELI G NOSARI A DECATALDO F PAOLINO F RESEGOTTI L COMOTTI B BARBUI T SCAPOLI GL CASTOLDI GL PROSSOMARITI L MONTUORI R RICCARDI A ASCARI E LANDOLFI R BIZZI B LOMBARDO M TORLONTANO G LEONI F FERRINI PR SPARAVENTI G DELFINI C PAPINESCHI F SPREMOLLA G BROCCIA G NARDELLI S CICCONE F DERIU L MIRAGLIA E DEBIASE R BODENIZZA CA CAROTENUTO M ROTONDO SG GENTILINI I COSER P CAPUCCI A IZZI T LUCIANO L ROTOLI B IACOPINO P NOBILE F CANTONETTI M PAPA G PINOTTI G SALA G FOA P MAIOLO MT AVANZINI P GOBBI F DORE F PARDINI S AMBROSETTI A PERONA G DINI D LIBERATI AM MARTELLI M GRIGNANI F MONTUORO A DELAURENZI A GALLO E PILERI A GALLAMINI A BUFFA F ABBADESSA A BRUZZESE L DEROSA C CIMINO R MANGONI L RIZZOLI V PIZZUTI M RICCIUTI F GALIENI P DISPENSA E ZAGONEL V PINTO A MUSOLINO C SQUADRITO G PERRICONE R CAJOZZO A MORANDI S BIANCHINI E MILIANI A MONACO M DIFRANCESCO A QUAGLINO D ROSTI G MARANGOLO M PASINI FL DIPERRI T AGLIETTA M GAVOSTO F
Citation: S. Tura et al., EVALUATING SURVIVAL AFTER ALLOGENEIC BONE-MARROW TRANSPLANT FOR CHRONIC MYELOID-LEUKEMIA IN CHRONIC PHASE - A COMPARISON OF TRANSPLANT VERSUS NO-TRANSPLANT IN A COHORT OF 258 PATIENTS 1ST SEEN IN ITALY BETWEEN1984 AND 1986, British Journal of Haematology, 85(2), 1993, pp. 292-299
Risultati: 1-14 |